Frontage Holdings Corporation (FGHQF)

Market Cap	253.60M -14.0%
Revenue (ttm)	256.69M +0.7%
Net Income	6.79M +758.8%
EPS	0.00 +745.9%
Shares Out	n/a
PE Ratio	37.33
Forward PE	14.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,000
Open	0.1100
Previous Close	n/a
Day's Range	0.1100 - 0.1100
52-Week Range	0.1100 - 0.1520
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Frontage Holdings

Frontage Holdings Corporation provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such a...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 1,523
• Stock Exchange: OTCMKTS
• Ticker Symbol: FGHQF

Financial Performance

In 2025, Frontage Holdings's revenue was $256.69 million, an increase of 0.70% compared to the previous year's $254.91 million. Earnings were $6.79 million, an increase of 758.79%.